John Field, an architect and self-described “urban choreographer” who strove to humanize shopping centers in the Bay Area and elsewhere, died of cancer at his home in San Francisco on Feb. 21. Rather than reshape the skyline, Mr. Field...Show More Summary
Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.
Jeffrey A. Drebin, MD, PhD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Drebin brings to MSK decades of experience as a world-class surgical oncologist specializing in pancreaticobiliary, upper gastrointestinal and liver surgery.
(Columbia University Medical Center) Bristol-Myers Squibb Company (NYSE:BMY) today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON).
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON).
(Boston University Medical Center) A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease. Researchers at Boston University School of Medicine (BUSM) have found that a genomic biomarker in the nasal passage can accurately determine the likelihood of a lung lesion being malignant.
Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson's disease.
A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer. The findings will be published February 24 in Science Immunology.
(Fred Hutchinson Cancer Research Center) A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer.The findings will be published February 24 in Science Immunology.
Today in Entertainment: Rihanna named Harvard Humanitarian of the Year; Sinéad O'Connor apologizes to Arsenio Hall for Prince comments Feb. 23, 2017, 9:55 a.m. With the Oscars around the corner and much of Hollywood still focused on the twists and turns of the presidency of Donald Trump, here's...
We often call out overly optimistic news coverage of drugs and devices. But information technology is another healthcare arena where uncritical media narratives can cause harm by raising false hopes and allowing costly and unproven investments to proceed without scrutiny. A case in point is the recent collapse of M.D. Anderson Cancer Center’s ambitious venture […]
(University of Texas M. D. Anderson Cancer Center) Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Story about the first patient enrolled in the new national phase I trial studying the side effects and best dose and schedule of pembrolizumab, an immunotherapy drug, when given together with chemotherapy and radiation therapy following surgery for very high risk head and neck cancer. Pembrolizumab is one of the first immunotherapy drugs.
(UNC Lineberger Comprehensive Cancer Center) Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center report in the journal Clinical Cancer Research that measuring patients' muscle mass and quality could potentially help doctors better identify patients at high risk for toxic side effects that could require hospitalizations.
(Memorial Sloan Kettering Cancer Center) Researchers from Memorial Sloan Kettering Cancer Center have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in m...
Researchers at The University of Kansas Cancer Center are collaborating on the "lab-on-a-chip," a testing platform that captures and performs analysis of various biomarkers, which are actively released by tumor cells into blood. Rather...Show More Summary
ORLANDO, Fla. — Mayo Clinic Cancer Center will host “Capture the Moment,” a free public cancer education symposium at the Ritz-Carlton at Orlando Grande Lakes, Florida, on March 25 from 7:30 a.m. to 6 p.m. EDT. This is the second consecutive year that Mayo Clinic Cancer Center has hosted this event in the Orlando area. […]
On CNN Tuesday afternoon, Steven Goldstein, director of the Anne Frank Center for Mutual Respect bashed lambasted President Donald Trump for his statement this morning denouncing bigotry, espcially anti-Semitism, and pinned recent Jew hatred on Trump's campaign, and now, administration. Show More Summary
(University of Texas M. D. Anderson Cancer Center) For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.
(University of Texas M. D. Anderson Cancer Center) Melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.